Centre of Excellence in Cardiovascular Minimally Invasive Devices
No Thumbnail Available
Date
2025-08-02
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
SCTIMST
Abstract
A Centre of Excellence in Cardiovascular Minimally Invasive Devices with a fund of ₹20 crores has been sanctioned in June 2024 by DBT. Ten cardiovascular devices that were identified along with the clinical team are proposed for development. High risk devices such as Transcatheter Aortic Valve Replacement (TAVR) device, Thoracic Aortic Stent Graft (ASG), Clot Retriever, Flow Modulator, Superficial Femoral Artery (SFA) stent, Patent Ductus Arteriosus (PDA) closure device, are some of the selected devices. These will be developed to the completion of proof-of-concept stage and made ready for technology transfer.
The COE was conceived to further expand and utilize the skills, strengths and IPR obtained during the Technical Research Center (TR) projects. Several equipment for design, in vitro evaluation and precision prototyping are included in the program. It is supported by several faculty of BMT Wing along with clinical faculty from the Interventional Radiology, Interventional Cardiology, as well as Cardiac and Neuro Surgery.